Biotech case studies
How our flexible approach helps small and mid sized biopharma clients develop transformative therapies and meet milestones to market.
Learn more about our experience by exploring our library of biotech case studies and find out how we help biotech meet critical milestones.
Enhancing strategic partnerships through streamlined EDC build processes
ICON collaborated with the trial sponsor to identify opportunities for improving specific processes related to electronic data capture (EDC) build for select studies.
Through a comprehensive SWOT analysis of a suite of studies, ICON identified areas for study build process improvements across the entire portfolio.
Through a comprehensive SWOT analysis of a suite of studies, ICON identified areas for study build process improvements across the entire portfolio.
Virtual Development Model
A venture-backed biopharmaceutical company focused on therapies for rare diseases needed to accelerate late-stage development and commercialization. ICON provided technical and commercial assessments, collaborating closely to simplify the development program and develop ePROs and a novel biomarker approach for the rare disease asset.
.jpg?crop=yes&w=1979&h=1041&a=0,140&itok=my95W7is "Boardroom Meeting (14)"){kind=icon}
FSP for a mid-sized device company
A mid-sized medical device company, required a smooth transition from using a staffing company alongside a full-service model, to an FSP model.
Success in early phase psoriasis study
A randomised, double-blind, placebo-controlled study on behalf of a biotechnology organisation to evaluate the safety, tolerability, and efficacy of the study drug in subjects with moderate to severe plaque psoriasis.